Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons.
Reinisch W, Melmed GY, Nakase H, Seidelin J, Ma C, Xuan S, Tran J, Remple V, Wegrzyn L, Levy G, Sanchez Gonzalez Y, Panaccione R. Reinisch W, et al. Among authors: tran j. Adv Ther. 2024 Oct;41(10):3832-3849. doi: 10.1007/s12325-024-02912-y. Epub 2024 Aug 10. Adv Ther. 2024. PMID: 39126596 Free PMC article.
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results.
Panés J, Loftus EV, Higgins PDR, Lindsay JO, Zhou W, Yao X, Ilo D, Phillips C, Tran J, Sanchez Gonzalez Y, Vermeire S. Panés J, et al. Among authors: tran j. Inflamm Bowel Dis. 2023 Sep 1;29(9):1421-1430. doi: 10.1093/ibd/izac260. Inflamm Bowel Dis. 2023. PMID: 36645051 Free PMC article. Clinical Trial.
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Danese S, Tran J, D'Haens G, Rubin DT, Aoyama N, Zhou W, Ilo D, Yao X, Sanchez Gonzalez Y, Panaccione R. Danese S, et al. Among authors: tran j. Inflamm Bowel Dis. 2023 Nov 2;29(11):1723-1729. doi: 10.1093/ibd/izad016. Inflamm Bowel Dis. 2023. PMID: 36790041 Free PMC article. Clinical Trial.
Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes.
Diehl K, Stoos E, Becker A, Orfaly VE, Nelson J, Gillespie J, Ng J, Tobey T, Latour E, Ludzik J, Berry EG, Geller AC, Jacobe H, Leitenberger J, McClanahan D, Tran J, Prasad S, Mengden-Koon S, Nelson KC, Petering R, Verdieck A, Savory S, Smith EH, Tofte S, Weinstock MA, White K, Wisco O, Curiel-Lewandrowski C, Swetter SM, Witkowski AM, Ferris L, Black S, Xu R, Xu S, Leachman S. Diehl K, et al. Among authors: tran j. Front Med (Lausanne). 2024 Dec 18;11:1500216. doi: 10.3389/fmed.2024.1500216. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39744535 Free PMC article.
Kinetic studies of bifurcating flavoproteins.
Hille R, Niks D, Vigil W Jr, Tran J, Ortiz S, Menjivar K, Nguyen D. Hille R, et al. Among authors: tran j. Arch Biochem Biophys. 2024 Dec 19;764:110278. doi: 10.1016/j.abb.2024.110278. Online ahead of print. Arch Biochem Biophys. 2024. PMID: 39709109 Free article. Review.
1,129 results